Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011.
Byrd JC, Rai K, Peterson BL, Appelbaum FR, Morrison VA, Kolitz JE, Shepherd L, Hines JD, Schiffer CA, Larson RA. Byrd JC, et al. Among authors: hines jd. Blood. 2005 Jan 1;105(1):49-53. doi: 10.1182/blood-2004-03-0796. Epub 2004 May 11. Blood. 2005. PMID: 15138165 Free article.
Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Morrison VA, Rai KR, Peterson BL, Kolitz JE, Elias L, Appelbaum FR, Hines JD, Shepherd L, Larson RA, Schiffer CA. Morrison VA, et al. Among authors: hines jd. J Clin Oncol. 2002 Sep 15;20(18):3878-84. doi: 10.1200/JCO.2002.08.128. J Clin Oncol. 2002. PMID: 12228208 Clinical Trial.
Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.
Martell RE, Peterson BL, Cohen HJ, Petros WP, Rai KR, Morrison VA, Elias L, Shepherd L, Hines J, Larson RA, Schiffer CA, Hurwitz HI. Martell RE, et al. Cancer Chemother Pharmacol. 2002 Jul;50(1):37-45. doi: 10.1007/s00280-002-0443-5. Epub 2002 Apr 27. Cancer Chemother Pharmacol. 2002. PMID: 12111110 Clinical Trial.
Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011.
Morrison VA, Rai KR, Peterson BL, Kolitz JE, Elias L, Appelbaum FR, Hines JD, Shepherd L, Martell RE, Larson RA, Schiffer CA. Morrison VA, et al. Among authors: hines jd. J Clin Oncol. 2001 Aug 15;19(16):3611-21. doi: 10.1200/JCO.2001.19.16.3611. J Clin Oncol. 2001. PMID: 11504743 Clinical Trial.
Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993).
Dutcher JP, Lee S, Gallagher RE, Makary AZ, Hines JD, Londer H, Farnen JP, Bennett JM, Paietta E, Rowe JM, Goloubeva O, Wiernik PH; Eastern Cooperative Oncology Group. Dutcher JP, et al. Among authors: hines jd. Leuk Lymphoma. 2005 Mar;46(3):377-85. doi: 10.1080/10428190400013100. Leuk Lymphoma. 2005. PMID: 15621827 Clinical Trial.
Letter: Ara-C and disseminated zoster.
Hines JD, Cowan DH, Nankervis GA. Hines JD, et al. N Engl J Med. 1975 Apr 3;292(14):755. N Engl J Med. 1975. PMID: 1113791 No abstract available.
Thrombocytopenia of severe alcoholism.
Cowan DH, Hines JD. Cowan DH, et al. Among authors: hines jd. Ann Intern Med. 1971 Jan;74(1):37-43. doi: 10.7326/0003-4819-74-1-37. Ann Intern Med. 1971. PMID: 5539275 No abstract available.
87 results